Zentalis Pharmaceuticals Inc (ZNTL)
10.98
-0.78
(-6.67%)
USD |
NASDAQ |
Apr 25, 16:00
10.98
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals Cash from Operations (Quarterly): -40.60M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -40.60M |
| September 30, 2023 | -38.66M |
| June 30, 2023 | -79.28M |
| March 31, 2023 | -49.28M |
| December 31, 2022 | -37.33M |
| September 30, 2022 | -33.20M |
| June 30, 2022 | -43.03M |
| March 31, 2022 | -50.20M |
| December 31, 2021 | -37.02M |
| September 30, 2021 | -33.49M |
| Date | Value |
|---|---|
| June 30, 2021 | -46.11M |
| March 31, 2021 | -37.47M |
| December 31, 2020 | -27.36M |
| September 30, 2020 | -20.56M |
| June 30, 2020 | -22.03M |
| March 31, 2020 | -16.87M |
| December 31, 2019 | -13.19M |
| September 30, 2019 | -9.988M |
| June 30, 2019 | -6.958M |
| March 31, 2019 | -9.006M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-79.28M
Minimum
Jun 2023
-6.958M
Maximum
Jun 2019
-33.82M
Average
-37.02M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
| Revolution Medicines Inc | -120.56M |
| Day One Biopharmaceuticals Inc | -41.37M |
| Perspective Therapeutics Inc | -9.008M |
| Electromed Inc | 3.471M |
| Xtant Medical Holdings Inc | -0.915M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -42.06M |
| Free Cash Flow | -208.40M |
| Free Cash Flow Per Share (Quarterly) | -0.5756 |
| Free Cash Flow Yield | -29.02% |